Keywords
Review
Colorectal Cancer
Vitamin D
How to Cite
Abstract
Introduction: Colorectal carcinoma is one of the cancers with a high disease burden globally. Previous observational studies have found a connection between colorectal cancer incidence with sunlight exposure and vitamin D levels. Subsequent studies investigated this relationship further and found various anti-tumoral pathways regulated by vitamin D in colorectal tissue. This paper aims to elucidate the actions of those pathways in preventing the malignant transformation of the colorectal cell by reviewing relevant literature.
Methods: A search was conducted on several medical literature electronic databases for original research studying the effects of vitamin D treatment on colorectal adenoma and colorectal cancer and its underlying anti-tumoral mechanism. A total of 122 studies were included for evaluation.
Results: Twenty-seven studies passed for analysis. These in vitro and in vivo study reveals that vitamin D treatment can suppress cell proliferation, induce apoptosis, maintain cellular differentiation, reduce the pro-inflammatory response, inhibit angiogenesis, and hinder metastatic progression in colorectal cancer and colorectal adenoma cells by regulating associated gene transcription or directly prevents activation of selected signalling pathways. Five studies have also shown that adding calcium to vitamin D treatment increases the anti-tumoral activity of vitamin D through cross-talk between both of their pathways.
Conclusion: Vitamin D could potentially impede colorectal cancer transformation and growth through interaction with various signalling pathways and regulating gene transcription. Further clinical studies are needed to confirm whether vitamin D can be used as the basis of targeted colorectal cancer therapy using its inherent anti-tumoral properties.
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394-424.
https://doi.org/10.3322/caac.21492
Rawla P, Sunkara T, Barsouk A. Epidemiology of colorectal cancer: incidence, mortality, survival, and risk factors. Gastroenterology Rev 2019; 14: 89-103.
https://doi.org/10.5114/pg.2018.81072
Lips P. Vitamin D physiology. Prog Biophys Mol Biol 2006; 92: 4-8.
https://doi.org/10.1016/j.pbiomolbio.2006.02.016
Nagpal S, Na S, Rathnachalam R. Noncalcemic Actions of Vitamin D Receptor Ligands. Endocrine Reviews 2005; 26: 662-87.
https://doi.org/10.1210/er.2004-0002
Garland CF, Garland FC. Do Sunlight and Vitamin D Reduce the Likelihood of Colon Cancer? Int J Epidemiol 1980; 9: 227-31.
https://doi.org/10.1093/ije/9.3.227
Garland CF, Garland FC, Shaw EK, Comstock GW, Helsing KJ, Gorham ED. Serum 25-hydroxyvitamin D and colon cancer: Eight-year prospective study. Lancet 1989; 334: 1176-8.
https://doi.org/10.1016/S0140-6736(89)91789-3
Wali RK, Khare S, Tretiakova M, Cohen G, Nguyen L, Hart J, et al. Ursodeoxycholic Acid and F6-D3 Inhibit Aberrant Crypt Proliferation in the Rat Azoxymethane Model of Colon Cancer: Roles of Cyclin D1 and E-Cadherin. Cancer Epidemiol Biomarkers Prev 2002; 11: 1653-62.
Yang K, Lamprecht SA, Shinozaki H, Fan K, Yang W, Newmark HL, et al. Dietary Calcium and Cholecalciferol Modulate Cyclin D1 Expression, Apoptosis, and Tumorigenesis in Intestine of adenomatous polyposis coli1638N/+ Mice. J Nutr 2008; 138: 1658-63.
https://doi.org/10.1093/jn/138.9.1658
Maier S, Daroqui MC, Scherer S, Roepcke S, Velcich A, Shenoy SM, et al. Butyrate and vitamin D3 induce transcriptional attenuation at the cyclin D1 locus in colonic carcinoma cells. J Cell Physiol 2009; 218: 638-42.
https://doi.org/10.1002/jcp.21642
Aggarwal A, Höbaus J, Tennakoon S, Prinz-Wohlgenannt M, Graça J, Price SA, et al. Active vitamin D potentiates the anti-neoplastic effects of calcium in the colon: A cross talk through the calcium-sensing receptor. J Steroid Biochem Mol Biol 2016; 155: 231-8.
https://doi.org/10.1016/j.jsbmb.2015.02.006
Evans SR, Soldatenkov V, Shchepotin EB, Bogrash E, Shchepotin IB. Novel 19-nor-hexafluoride vitamin D3 analog (Ro 25-6760) inhibits human colon cancer in vitro via apoptosis. Int J Oncol 1999.
https://doi.org/10.3892/ijo.14.5.979
Wilson AJ, Velcich A, Arango D, Kurland AR, Shenoy SM, Pezo RC, et al. Novel Detection and Differential Utilization of a c-myc Transcriptional Block in Colon Cancer Chemoprevention. Cancer Res 2002; 62: 6006-10.
Fichera A, Little N, Dougherty U, Mustafi R, Cerda S, Li YC, et al. A Vitamin D Analogue Inhibits Colonic Carcinogenesis in the AOM/DSS Model. J Surg Res 2007; 142: 239-45.
https://doi.org/10.1016/j.jss.2007.02.038
Chen S, Bu D, Ma Y, Zhu J, Chen G, Sun L, et al. H19 Overexpression Induces Resistance to 1,25(OH)2D3 by Targeting VDR Through miR-675-5p in Colon Cancer Cells. Neoplasia 2017; 19: 226-36.
https://doi.org/10.1016/j.neo.2016.10.007
Murillo G, Mehta RG. Chemoprevention of chemically-in-duced mammary and colon carcinogenesis by 1α-hydroxy-vitamin D5. J Steroid Biochem Mol Biol 2005; 97: 129-36.
https://doi.org/10.1016/j.jsbmb.2005.06.008
Ahearn TU, Shaukat A, Flanders WD, Rutherford RE, Bostick RM. A Randomized Clinical Trial of the Effects of Supplemental Calcium and Vitamin D3 on the APC/β-Catenin Pathway in the Normal Mucosa of Colorectal Adenoma Patients. Cancer Prev Res 2012; 5: 1247-56.
https://doi.org/10.1158/1940-6207.CAPR-12-0292
Liu S, Barry EL, Baron JA, Rutherford RE, Seabrook ME, Bostick RM. Effects of supplemental calcium and vitamin D on the APC/β-catenin pathway in the normal colorectal mucosa of colorectal adenoma patients. Mol Carcinog 2017; 56: 412-24.
https://doi.org/10.1002/mc.22504
Samanta S, Chatterjee M, Ghosh B, Rajkumar M, Rana A, Chatterjee M. Vanadium and 1, 25 (OH)2 vitamin D3 combination in inhibitions of 1,2, dimethylhydrazine-induced rat colon carcinogenesis. Biochim Biophys Acta 2008; 1780: 1106-14.
https://doi.org/10.1016/j.bbagen.2008.05.003
Pálmer HG, González-Sancho JM, Espada J, Berciano MT, Puig I, Baulida J, et al. Vitamin D3 promotes the differentiation of colon carcinoma cells by the induction of E-cadherin and the inhibition of β-catenin signaling. Journal of Cell Biology 2001; 154: 369-88.
https://doi.org/10.1083/jcb.200102028
Xu H, Posner GH, Stevenson M, Campbell FC. Apc MIN modulation of vitamin D secosteroid growth control. Carcinogenesis 2010; 31: 1434-41.
https://doi.org/10.1093/carcin/bgq098
Xin Y, He L, Luan Z, Lv H, Yang H, Zhou Y, et al. E-cadherin Mediates the Preventive Effect of Vitamin D3 in Colitis-associated Carcinogenesis. Inflamm Bowel Dis 2017; 23: 1535-43.
https://doi.org/10.1097/MIB.0000000000001209
Aguilera O, Pena C, Garcia JM, Larriba MJ, Ordonez-Moran P, Navarro D, et al. The Wnt antagonist DICKKOPF-1 gene is induced by 1 ,25-dihydroxyvitamin D3 associated to the differentiation of human colon cancer cells. Carcinogenesis 2007; 28: 1877-84.
https://doi.org/10.1093/carcin/bgm094
Deevi RK, McClements J, McCloskey KD, Fatehullah A, Tkocz D, Javadi A, et al. Vitamin D3 suppresses morphological evolution of the cribriform cancerous phenotype. Oncotarget 2016; 7: 49042-64.
https://doi.org/10.18632/oncotarget.8863
Franceschi RT, Linson CJ, Peter TC, Romano PR. Regulation of cellular adhesion and fibronectin synthesis by 1 alpha, 25-dihydroxyvitamin D3. J Biol Chem 1987; 262: 4165-71.
Makishima M. Vitamin D Receptor As an Intestinal Bile Acid Sensor. Science 2002; 296: 1313-6.
https://doi.org/10.1126/science.1070477
Dıaz GD, Paraskeva C, Thomas MG, Binderup L, Hague A. Apoptosis Is Induced by the Active Metabolite of Vitamin D3 and Its Analogue EB1089 in Colorectal Adenoma and Carcinoma Cells: Possible Implications for Prevention and Therapy. Cancer Res 2000; 60: 2304-12.
Bessler H, Djaldetti M. 1α,25-dihydroxyvitamin D3 modulates the interaction between immune and colon cancer cells. Biomed Pharmacother 2012; 66: 428-32.
https://doi.org/10.1016/j.biopha.2012.06.005
Murillo G, Nagpal V, Tiwari N, Benya RV, Mehta RG. Actions of vitamin D are mediated by the TLR4 pathway in inflammation-induced colon cancer. J Steroid Biochem Mol Biol 2010; 121: 403-7.
https://doi.org/10.1016/j.jsbmb.2010.03.009
Meeker S, Seamons A, Paik J, Treuting PM, Brabb T, Grady WM, et al. Increased Dietary Vitamin D Suppresses MAPK Signaling, Colitis, and Colon Cancer. Cancer Res 2014; 74: 4398-408.
https://doi.org/10.1158/0008-5472.CAN-13-2820
Hopkins MH, Owen J, Ahearn T, Fedirko V, Flanders WD, Jones DP, et al. Effects of Supplemental Vitamin D and Calcium on Biomarkers of Inflammation in Colorectal Adenoma Patients: A Randomized, Controlled Clinical Trial. Cancer Prev Res 2011; 4: 1645-54.
https://doi.org/10.1158/1940-6207.CAPR-11-0105
Iseki K, Tatsuta M, Uehara H, IIshi H, Yano H, Sakai N, et al. Inhibition of angiogenesis as a mechanism for inhibition by Lα‐hydroxyvitamin D3 and 1,25‐dihydroxyvitamin D3 of colon carcinogenesis induced by azoxymethane in Wistar rats. Int J Cancer 1999; 81: 730-3.
https://doi.org/10.1002/(sici)1097-0215(19990531)81:5<730::aid-ijc11>3.0.co;2-q
Ben-Shoshan M, Amir S, Dang DT, Dang LH, Weisman Y, Mabjeesh NJ. 1α,25-dihydroxyvitamin D3 (Calcitriol) inhibits hypoxia-inducible factor-1/vascular endothelial growth factor pathway in human cancer cells. Mol Cancer Ther 2007; 6: 1433-9.
https://doi.org/10.1158/1535-7163.MCT-06-0677
Chen S, Zhu J, Zuo S, Ma J, Zhang J, Chen G, et al. 1,25(OH)2D3 attenuates TGF-β1/β2-induced increased migration and invasion via inhibiting epithelial-mesenchymal transition in colon cancer cells. Biochem Biophys Res Commun 2015; 468: 130-5.
https://doi.org/10.1016/j.bbrc.2015.10.146
Nguyen H, Duong H. The molecular characteristics of colorectal cancer: Implications for diagnosis and therapy (Review). Oncol Lett 2018; 16: 9-18.
https://doi.org/10.3892/ol.2018.8679
Dovnik A, Dovnik NF. Vitamin D and Ovarian Cancer: Systematic Review of the Literature with a Focus on Molecular Mechanisms. Cells 2020; 9: 335.
https://doi.org/10.3390/cells9020335
Moreno J, Krishnan AV, Feldman D. Molecular mechanisms mediating the anti-proliferative effects of Vitamin D in prostate cancer. J Steroid Biochem Mol Biol 2005; 97: 31-6.
https://doi.org/10.1016/j.jsbmb.2005.06.012
Krishnan AV, Feldman D. Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment. Endocr Relat Cancer 2010; 17: R19-38.
https://doi.org/10.1677/ERC-09-0139
Krishnan AV, Swami S, Feldman D. Vitamin D and breast cancer: Inhibition of estrogen synthesis and signaling. J Steroid Biochem Mol Biol 2010; 121: 343-8.
https://doi.org/10.1016/j.jsbmb.2010.02.009
Krishnan AV, Swami S, Feldman D. The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer. Steroids 2012; 77: 1107-12.
https://doi.org/10.1016/j.steroids.2012.06.005
Grau MV, Baron JA, Sandler RS, Haile RW, Beach ML, Church TR, et al. Vitamin D, Calcium Supplementation, and Colorectal Adenomas: Results of a Randomized Trial. J Natl Cancer Inst 2003; 95: 1765-71.
https://doi.org/10.1093/jnci/djg110
Lappe JM, Travers-Gustafson D, Davies KM, Recker RR, Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007; 85: 1586-91.
https://doi.org/10.1093/ajcn/85.6.1586
Bises G, Kállay E, Weiland T, Wrba F, Wenzl E, Bonner E, et al. 25-Hydroxyvitamin D3 -1α-hydroxylase Expression in Normal and Malignant Human Colon. J Histochem Cytochem 2004; 52: 985-9.
https://doi.org/10.1369/jhc.4B6271.2004
Matusiak D. Expression of Vitamin D Receptor and 25-Hydroxyvitamin D3-1 -Hydroxylase in Normal and Malignant Human Colon. Cancer Epidemiol Biomarkers Prev 2005; 14: 2370-6.
https://doi.org/10.1158/1055-9965.EPI-05-0257
Horváth HC, Lakatos P, Kósa JP, Bácsi K, Borka K, Bises G, et al. The Candidate Oncogene CYP24A1: A Potential Biomarker for Colorectal Tumorigenesis. J Histochem Cytochem 2010; 58: 277-85.
https://doi.org/10.1369/jhc.2009.954339
Lopes N, Sousa B, Martins D, Gomes M, Vieira D, Veronese LA, et al. Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions. BMC Cancer 2010; 483.
https://doi.org/10.1186/1471-2407-10-483
Hendrickson WK, Flavin R, Kasperzyk JL, Fiorentino M, Fang F, Lis R, et al. Vitamin D Receptor Protein Expression in Tumor Tissue and Prostate Cancer Progression. J Clin Oncol 2011; 29: 2378-85.
https://doi.org/10.1200/JCO.2010.30.9880
Brożyna AA, Jóźwicki W, Jochymski C, Slominski AT. Decreased expression of CYP27B1 correlates with the increased aggressiveness of ovarian carcinomas. Oncol Rep 2015; 33: 599-606.
https://doi.org/10.3892/or.2014.3666
Mittal MK, Myers JN, Misra S, Bailey CK, Chaudhuri G. In vivo binding to and functional repression of the VDR gene promoter by SLUG in human breast cells. Biochem Biophys Res Commun 2008; 372: 30-4.
https://doi.org/10.1016/j.bbrc.2008.04.187
Stambolsky P, Tabach Y, Fontemaggi G, Weisz L, Maor-Aloni R, Sigfried Z, et al. Modulation of the Vitamin D3 Response by Cancer-Associated Mutant p53. Cancer Cell 2010; 17: 273-85.
https://doi.org/10.1016/j.ccr.2009.11.025
Komagata S, Nakajima M, Takagi S, Mohri T, Taniya T, Yokoi T. Human CYP24 Catalyzing the Inactivation of Calcitriol Is Post-Transcriptionally Regulated by miR-125b. Mol Pharmacol 2009; 76: 702-9.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2021 Fauzan Herdian, Fahmi Radityamurti, Tiara Bunga Mayang Permata, Handoko, Henry Kodrat, Endang Nuryadi, Heri Wibowo, Soehartati Gondhowiardjo